Literature DB >> 12700308

Pseudoseizures and asthma.

C J de Wet1, J D C Mellers, W N Gardner, B K Toone.   

Abstract

BACKGROUND: Sexual abuse and head injury are important risk factors of pseudoseizures, reported in about a third of patients. Clinical experience suggests that asthma is another possible risk factor.
OBJECTIVES: To determine the relative prevalence of asthma in patients with pseudoseizures.
METHODS: A retrospective record review was undertaken of reported asthma in 102 patients with pseudoseizures and 70 psychotic controls. The pseudoseizure patients were subgrouped according to method of diagnosis: 47 in whom epilepsy was excluded by capturing a typical attack on video-electroencephalographic monitoring (VEEM), and 55 not diagnostically confirmed with VEEM.
RESULTS: Asthma was reported in 26.5% of pseudoseizure patients, compared with 8.6% of the psychotic controls (chi(2) = 8.6; p = 0.003). Asthma was reported at similar rates in the VEEM confirmed (29.8%) and non-VEEM confirmed (23.6%) pseudoseizure subgroups. The significant excess of reported asthma held for both the VEEM confirmed subjects (Pearson's chi(2) = 5.4, p = 0.02) and non-VEEM confirmed subjects (Pearson's chi(2) = 8.9, p = 0.003).
CONCLUSIONS: There is an association between pseudoseizures and reported asthma. Various models are proposed whereby somatisation, anxiety hyperventilation, and dissociative elaboration may account for the observed association. Both asthma and anxiety hyperventilation may be important risk factors for the development of pseudoseizures. The reported asthma may itself be psychogenic in origin in a proportion of patients. Confirmatory prospective studies are indicated.

Entities:  

Mesh:

Year:  2003        PMID: 12700308      PMCID: PMC1738427          DOI: 10.1136/jnnp.74.5.639

Source DB:  PubMed          Journal:  J Neurol Neurosurg Psychiatry        ISSN: 0022-3050            Impact factor:   10.154


  7 in total

Review 1.  How to avoid a misdiagnosis in patients presenting with transient loss of consciousness.

Authors:  Sanjiv Petkar; Paul Cooper; Adam P Fitzpatrick
Journal:  Postgrad Med J       Date:  2006-10       Impact factor: 2.401

Review 2.  Conversion Disorder, Functional Neurological Symptom Disorder, and Chronic Pain: Comorbidity, Assessment, and Treatment.

Authors:  Patricia Tsui; Andrew Deptula; Derek Y Yuan
Journal:  Curr Pain Headache Rep       Date:  2017-06

Review 3.  The approach to patients with "non-epileptic seizures".

Authors:  J D C Mellers
Journal:  Postgrad Med J       Date:  2005-08       Impact factor: 2.401

4.  Identifying psychogenic seizures through comorbidities and medication history.

Authors:  Wesley T Kerr; Emily A Janio; Chelsea T Braesch; Justine M Le; Jessica M Hori; Akash B Patel; Norma L Gallardo; Janar Bauirjan; Shannon R D'Ambrosio; Andrea M Chau; Eric S Hwang; Emily C Davis; Albert Buchard; David Torres-Barba; Mona Al Banna; Sarah E Barritt; Andrew Y Cho; Jerome Engel; Mark S Cohen; John M Stern
Journal:  Epilepsia       Date:  2017-09-12       Impact factor: 5.864

5.  Reliability of self-reported diagnoses in patients with neurologically unexplained symptoms.

Authors:  A Schrag; R J Brown; M R Trimble
Journal:  J Neurol Neurosurg Psychiatry       Date:  2004-04       Impact factor: 10.154

6.  The diagnostic and therapeutic challenge of nonepileptic seizures: An interdisciplinary approach.

Authors:  Shirley Ferguson Rayport; Carolyn A Schell
Journal:  Epilepsy Behav Case Rep       Date:  2014-04-22

7.  Is Seizure an Adverse Effect of Salbutamol in the Pediatric Population?

Authors:  Metin Uysalol; Raif Yıldız; Zeynep Güneş Özünal
Journal:  Balkan Med J       Date:  2022-07-18       Impact factor: 3.570

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.